Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul W O'Connor

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 31, 2012
Natalizumab risk stratification: role of a two- step anti-JCV antibody assayPaul W O'Connor
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 23, 2010
Use of natalizumab in multiple sclerosis patientsPaul W O'Connor
Current Opinion in Neurology|April 30, 2015
Established disease-modifying treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
Current Opinion in Neurology|April 19, 2015
Novel and imminently emerging treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 28, 2015
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 UpdatePaul W O'Connor, Marcelo Kremenchutzky
Seminars in Neurology|May 28, 2013
Teriflunomide for the treatment of multiple sclerosisJiwon Oh, Paul W O'Connor
Neurology. Clinical Practice|August 6, 2013
TeriflunomideJiwon Oh, Paul W O'Connor
Nature Reviews. Neurology|January 14, 2015
Multiple sclerosis in 2014. Progress in MS--classification, mechanisms and treatmentJiwon Oh, Paul W O'Connor
Therapeutic Advances in Neurological Disorders|October 25, 2014
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospectsJiwon Oh, Paul W O'Connor
CNS Drugs|June 27, 2013
Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 31, 2012
Natalizumab risk stratification: role of a two- step anti-JCV antibody assayPaul W O'Connor
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 23, 2010
Use of natalizumab in multiple sclerosis patientsPaul W O'Connor
Current Opinion in Neurology|April 30, 2015
Established disease-modifying treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
Current Opinion in Neurology|April 19, 2015
Novel and imminently emerging treatments in relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 28, 2015
Use of Natalizumab in Patients with Multiple Sclerosis: 2015 UpdatePaul W O'Connor, Marcelo Kremenchutzky
Seminars in Neurology|May 28, 2013
Teriflunomide for the treatment of multiple sclerosisJiwon Oh, Paul W O'Connor
Neurology. Clinical Practice|August 6, 2013
TeriflunomideJiwon Oh, Paul W O'Connor
Nature Reviews. Neurology|January 14, 2015
Multiple sclerosis in 2014. Progress in MS--classification, mechanisms and treatmentJiwon Oh, Paul W O'Connor
Therapeutic Advances in Neurological Disorders|October 25, 2014
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospectsJiwon Oh, Paul W O'Connor
CNS Drugs|June 27, 2013
Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'Connor
Pageof 5